Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma

Br J Haematol. 2023 Apr;201(2):e12-e15. doi: 10.1111/bjh.18688. Epub 2023 Feb 12.

Authors

Affiliations

¹ Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
² Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
³ Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.

PMID: 36775956
DOI: 10.1111/bjh.18688

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Endoplasmic Reticulum Stress
Endoribonucleases
Lymphoma, Primary Effusion* / drug therapy
Mice
Protein Serine-Threonine Kinases
eIF-2 Kinase

Substances

eIF-2 Kinase
Endoribonucleases
Ern1 protein, mouse
Protein Serine-Threonine Kinases
PERK kinase